论文部分内容阅读
目的探究炎琥宁注射联合干扰素治疗小儿腮腺炎的临床疗效。方法选取2014年11月至2016年1月我院住院治疗106例小儿腮腺炎患儿为研究对象,随机分为采用常规炎治疗的对照组(53例)和采用炎琥宁注射液联合干扰素治疗的观察组(53例),比较两组患儿的临床症状消退时间和治疗效果。结果炎琥宁注射液联合干扰素治疗小儿腮腺炎的总有效(96.23%)明显优于单独采用炎琥宁注射液治疗的对照组总有效(83.02%),差异有统计学意义(P<0.05);且观察组患儿发热和消肿的时间明显优于对照组,差异有统计学意义(P<0.05)。结论炎琥宁注射液联合干扰素治疗小儿腮腺炎的临床效果显著,有效改善患儿临床症状,值得临床推广。
Objective To investigate the clinical efficacy of combining Yanhuning injection with interferon in the treatment of mumps in children. Methods From November 2014 to January 2016, 106 children with mumps were hospitalized in our hospital. The children were randomly divided into the control group (53 cases) treated with conventional inflammation and the combination of Yan Hu Ning Injection and interferon Treatment of the observation group (53 cases), two groups of children with clinical symptoms of subsided time and treatment. Results The total effective rate (96.23%) of Yanhuoning injection combined with interferon in children with mumps was significantly better than that of the control group treated with Yanhuoning injection alone (83.02%), the difference was statistically significant (P <0.05 ); And the observation group children with fever and swelling of the time was significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion Yan Hu Ning injection combined with interferon in the treatment of children with mumps significant clinical effect, effectively improve the clinical symptoms of children, it is worth clinical promotion.